Skip to main content
Clinical Trials/ACTRN12619000441112
ACTRN12619000441112
Recruiting
未知

iving Well after Breast Cancer: a pilot study exploring physiological differences between women with premenopausal breast cancer, and postmenopausal women with breast cancer, and their response to a partial meal replacement dietary intervention

The University of Queensland0 sites20 target enrollmentMarch 18, 2019

Overview

Phase
未知
Intervention
Not specified
Conditions
Breast cancer
Sponsor
The University of Queensland
Enrollment
20
Status
Recruiting
Last Updated
6 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
March 18, 2019
End Date
TBD
Last Updated
6 years ago
Study Type
Interventional
Sex
Female

Investigators

Eligibility Criteria

Inclusion Criteria

  • Women with premenopausal breast cancer
  • \-Diagnosed with invasive breast cancer (stage I\-IIIc)
  • \-Oestrogen receptor positive disease (ER\+)
  • \-Premenopausal at diagnosis
  • \-BMI greater than or equal to 27kg/m2
  • \-Finished primary treatment (i.e. surgery, chemotherapy and/or radiotherapy)
  • \-Received chemotherapy treatment for breast cancer
  • Women with postmenopausal breast cancer
  • Diagnosed with invasive breast cancer (stage I\-IIIc)
  • Oestrogen receptor positive disease (ER\+)

Exclusion Criteria

  • Women with premenopausal breast cancer
  • \-Ductal carcinoma in situ (DCIS; stage 0\), distant metastases (stage IV) or triple negative breast cancer (TNBC)
  • \-Diagnosed more than two years ago
  • \-Currently pregnant or plan to conceive during the study period
  • \-Contraindication to participating in an unsupervised program \- active heart disease, impaired mobility, Insulin dependent diabetes, low liver/kidney function (from blood test)
  • \-Currently taking or planning to start taking weight loss medications
  • \-Insufficient English to complete assessments and participate in the intervention
  • \-Unable to travel to Brisbane to complete study assessments
  • \-Reporting depression/anxiety as a current significant problem that would interfere with study participation.
  • \-Allergy or intolerance to soy, dairy or lactose

Outcomes

Primary Outcomes

Not specified

Similar Trials